Amalgamated Bank Has $2.68 Million Holdings in Exponent, Inc. (NASDAQ:EXPO)

Amalgamated Bank decreased its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 5.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,239 shares of the business services provider’s stock after selling 1,378 shares during the quarter. Amalgamated Bank’s holdings in Exponent were worth $2,679,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Quarry LP acquired a new position in shares of Exponent during the 2nd quarter worth about $25,000. GAMMA Investing LLC raised its holdings in Exponent by 67.7% during the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock worth $36,000 after acquiring an additional 153 shares in the last quarter. Whittier Trust Co. of Nevada Inc. boosted its position in Exponent by 166.5% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after purchasing an additional 323 shares during the last quarter. USA Financial Formulas bought a new position in Exponent in the third quarter valued at approximately $60,000. Finally, Benjamin F. Edwards & Company Inc. increased its position in shares of Exponent by 70.5% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider’s stock worth $83,000 after purchasing an additional 361 shares during the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Truist Financial reissued a “buy” rating and issued a $120.00 price objective (up previously from $100.00) on shares of Exponent in a report on Friday, July 26th.

Exponent Stock Performance

Shares of EXPO stock opened at $104.97 on Monday. Exponent, Inc. has a 52-week low of $68.70 and a 52-week high of $115.75. The stock has a market cap of $5.33 billion, a price-to-earnings ratio of 50.71 and a beta of 0.69. The firm’s 50-day moving average is $107.64 and its 200-day moving average is $101.72.

Exponent Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be paid a $0.28 dividend. The ex-dividend date of this dividend is Friday, December 6th. This represents a $1.12 annualized dividend and a yield of 1.07%. Exponent’s dividend payout ratio is 54.11%.

Insider Activity

In related news, Director Paul R. Johnston sold 14,000 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total value of $1,464,400.00. Following the sale, the director now owns 80,742 shares in the company, valued at approximately $8,445,613.20. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Carol Lindstrom sold 1,039 shares of the company’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the transaction, the director now owns 5,871 shares in the company, valued at approximately $565,494.72. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Paul R. Johnston sold 14,000 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total transaction of $1,464,400.00. Following the completion of the transaction, the director now directly owns 80,742 shares in the company, valued at approximately $8,445,613.20. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.10% of the company’s stock.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.